Search research articles
Contact Us
Filters
Showing results (11-20 of 328) with videos related to
Page
of 33
Sort By:
Current Treatment Options in Neurology
|
September 21, 2014
Treatment of frontotemporal dementia
Richard M Tsai, Adam L Boxer
Journal of Neurochemistry
|
June 17, 2016
Therapy and clinical trials in frontotemporal dementia: past, present, and future
Richard M Tsai, Adam L Boxer
The Clinical Neuropsychologist
|
September 28, 2019
Cognitive decline on the Repeatable Battery for the Assessment of Neuropsychological Status in progressive supranuclear palsy
Kevin Duff, Christopher Randolph, Adam L Boxer
Neuroscience Letters
|
May 8, 2020
Targeting tau: Clinical trials and novel therapeutic approaches
Lawren VandeVrede, Adam L Boxer, Manuela Polydoro
Annals of Neurology
|
June 1, 1983
Hematological monitoring during therapy with carbamazepine in children
F S Silverstein, L Boxer, M V Johnston
The Lancet. Neurology
|
July 19, 2024
Clinical versus biomarker-based diagnosis of neurocognitive disorders
Günter U Höglinger, Adam L Boxer, Anthony E Lang
Liver
|
February 1, 1989
Liver cell rosettes: structural differences in cholestasis and hepatitis
N Nagore, S Howe, L Boxer, et al.
Blood
|
June 1, 1980
The chronic idiopathic neutropenia syndrome: correlation of clinical features with in vitro parameters of granulocytopoiesis
P L Greenberg, B Mara, S Steed, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 9, 2020
Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS
Howard J Rosen, Bradley F Boeve, Adam L Boxer
Frontiers in Neurology
|
September 25, 2018
24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome
Ingemar Björkhem, Kalicharan Patra, Adam L Boxer, et al.
Page
of 33
Search research articles
Search
Showing results (11-20 of 328) with videos related to
Sort By:
Page
of 33
Current Treatment Options in Neurology
|
September 21, 2014
Treatment of frontotemporal dementia
Richard M Tsai, Adam L Boxer
Journal of Neurochemistry
|
June 17, 2016
Therapy and clinical trials in frontotemporal dementia: past, present, and future
Richard M Tsai, Adam L Boxer
The Clinical Neuropsychologist
|
September 28, 2019
Cognitive decline on the Repeatable Battery for the Assessment of Neuropsychological Status in progressive supranuclear palsy
Kevin Duff, Christopher Randolph, Adam L Boxer
Neuroscience Letters
|
May 8, 2020
Targeting tau: Clinical trials and novel therapeutic approaches
Lawren VandeVrede, Adam L Boxer, Manuela Polydoro
Annals of Neurology
|
June 1, 1983
Hematological monitoring during therapy with carbamazepine in children
F S Silverstein, L Boxer, M V Johnston
The Lancet. Neurology
|
July 19, 2024
Clinical versus biomarker-based diagnosis of neurocognitive disorders
Günter U Höglinger, Adam L Boxer, Anthony E Lang
Liver
|
February 1, 1989
Liver cell rosettes: structural differences in cholestasis and hepatitis
N Nagore, S Howe, L Boxer, et al.
Blood
|
June 1, 1980
The chronic idiopathic neutropenia syndrome: correlation of clinical features with in vitro parameters of granulocytopoiesis
P L Greenberg, B Mara, S Steed, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 9, 2020
Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS
Howard J Rosen, Bradley F Boeve, Adam L Boxer
Frontiers in Neurology
|
September 25, 2018
24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome
Ingemar Björkhem, Kalicharan Patra, Adam L Boxer, et al.
Page
of 33